CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+16.35%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$995M
AUM Growth
+$995M
(-9.4%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-10.32%
Top 10 Holdings %
Top 10 Hldgs %
79.85%
Holding
33
New
6
Increased
13
Reduced
8
Closed
5
Top Buys
| 1 |
INSY
Insys Therapeutics, Inc.
INSY
|
$58.4M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$36.2M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$26.6M |
| 4 |
Pacific Biosciences
PACB
|
$19.6M |
| 5 |
Celldex Therapeutics
CLDX
|
$19M |
Top Sells
| 1 |
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
|
$87.3M |
| 2 |
United Therapeutics
UTHR
|
$56.5M |
| 3 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$48M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
$43.1M |
| 5 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$34.9M |
Sector Composition
| 1 | Healthcare | 83.48% |
| 2 | Technology | 0.16% |
| 3 | Financials | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMPR
26
DELISTED
IMPRIVATA, INC COM
IMPR
| $1.57M | 0.16% | +95,759 | New | +$1.57M |
|
|
BIOL
27
DELISTED
Biolase, Inc.
BIOL
| $1.16M | 0.12% | +667,664 | New | +$1.16M |
|
28
eHealth
EHTH
$118M
| $67K | 0.01% | 5,242 -47,658 | -90% | -$609K |
|
29
Protalix BioTherapeutics
PLX
$124M
| – | – | -5,643,750 | Closed | -$10M |
|
|
30
Supernus Pharmaceuticals
SUPN
$2.53B
| – | – | -3,566,923 | Closed | -$43.1M |
|
|
PTX
31
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| – | – | -3,261,484 | Closed | -$34.9M |
|
|
HPTX
32
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| – | – | -1,901,930 | Closed | -$87.3M |
|
|
ANAC
33
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| – | – | -830,151 | Closed | -$48M |
|